Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
EXEL.OQ - Exelixis Inc
Exelixis Inc at Jefferies Global Healthcare Conference in New York
Jun 03, 2026 / 03:05PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, good morning, everyone. I really do appreciate it. My name is Akash Jawari. I head our performant biotech efforts on the research side here at Jefferies and I have the pleasure of hosting the Exelaxis management team, which again is a commercial stage company that is in several different tumor types and is a leader. Kind of in renal carcinoma, but then also has ambitions to really think about VEGF inhibition in a broader subset of diseases and that's what they're explaining, looking at with Zanza.
Andrew, why don't I hand it off to you for some intro remarks and then we'll get started.
--------------------------------------------------------------------------------
Unidentified_2 [2]
-

